PHYTONADIONE

Post-LOE

phytonadione

Dr. Reddy's Laboratories

ANDAINJECTIONINJECTABLE

Approved

May 2019

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

PHYTONADIONE (phytonadione) by Dr. Reddy's Laboratories is clinical pharmacology phytonadione injectable emulsion, is indicated in the following coagulation disorders which are due to faulty formation of factors ii, vii, ix and x when caused by vitamin k deficiency or interference with vitamin k activity. Approved for the following coagulation disorders which are due to faulty formation of factors ii, interference with vitamin k activity, ulcerative colitis. First approved in 2019.

Drug data last refreshed 1w ago

Mechanism of Action

CLINICAL PHARMACOLOGY Phytonadione injectable emulsion, is indicated in the following coagulation disorders which are due to faulty formation of factors II, VII, IX and X when caused by Vitamin K deficiency or interference with Vitamin K activity. Phytonadione injectable emulsion is indicated in: •…

Pharmacologic Class:

Vitamin K

Indications (3)

the following coagulation disorders which are due to faulty formation of factors II

Worked on PHYTONADIONE at Dr. Reddy's Laboratories? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.